AT
Posted:
June 01, 2026
Location:
Remote, Remote, Canada
Job Description
Lead M&A strategy as a manager focused on life sciences growth. Engage in market analysis, strategic planning, and portfolio management while driving outcomes through collaboration.
In this pivotal role, you will guide organic and inorganic growth initiatives, interfacing with senior life sciences leaders and cross-functional teams to deliver insights that support investment decisions. Your ability to influence stakeholders will be key to navigating complex strategic discussions.
Key Responsibilities:
• Lead market and competitive opportunity identification
• Shape the strategic planning for the Group
• Conduct portfolio analysis to inform investments
• Facilitate M&A lifecycle processes and negotiations
• Manage cross-functional teams for project execution
Requirements:
• 5+ years of relevant strategy or M&A experience
• Proven record in consulting or corporate development
• Bachelor’s degree required; CPA or CFA preferred
• Demonstrated analytical ...
In this pivotal role, you will guide organic and inorganic growth initiatives, interfacing with senior life sciences leaders and cross-functional teams to deliver insights that support investment decisions. Your ability to influence stakeholders will be key to navigating complex strategic discussions.
Key Responsibilities:
• Lead market and competitive opportunity identification
• Shape the strategic planning for the Group
• Conduct portfolio analysis to inform investments
• Facilitate M&A lifecycle processes and negotiations
• Manage cross-functional teams for project execution
Requirements:
• 5+ years of relevant strategy or M&A experience
• Proven record in consulting or corporate development
• Bachelor’s degree required; CPA or CFA preferred
• Demonstrated analytical ...
Apply for this Job
Submit your application for the Life Sciences M&A Strategy Manager position at ATS Corporation.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Remote, Canada
Posted:
June 01, 2026
Deadline:
July 11, 2026